Description
NSC-139021 (ERGi-USU) is a highly selective inhibitor for the growth of ERG-positive cancer cells with IC₅₀s ranging from 30 to 400 nM. NSC-139021 displays minimal effect on normal prostate or endothelial cells or ERG-negative tumor cell lines.
NSC-139021 (ERGi-USU) is a highly selective inhibitor for the growth of ERG-positive cancer cells with IC₅₀s ranging from 30 to 400 nM. NSC-139021 displays minimal effect on normal prostate or endothelial cells or ERG-negative tumor cell lines.
Alternate Name/Synonyms: 1-(2-Thiazolylazo)-2-naphthol; 1-(2-Thiazoylazo)-2-naphthol; 1147-56-4; MLS000738280; 2-Naphthol, 1-(2-thiazolylazo); TAN
Appearance: Dark orange to red solid
Formulation: N/A
CAS Number: 1147-56-4
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₁₃H₉N₃OS
Molecular Weight: 255.3
Cell-Permeable?: Yes
Purity: ≥98% by HPLC
Solubilities: DMSO
Handling: Protect from air and light
Country of Origin: USA
Tag Line: A highly selective inhibitor for the growth of ERG-positive cancer cells
MDL Number: MFCD00021611
PubChem CID: 6308684
SMILES: C1=CC=C2C(=C1)C=CC(=O)C2=NNC3=NC=CS3
InChi: InChI=1S/C13H9N3OS/c17-11-6-5-9-3-1-2-4-10(9)12(11)15-16-13-14-7-8-18-13/h1-8H,(H,14,16)/b15-12-
InChi Key: GCBAKGGJQPMJLL-QINSGFPZSA-N
Additional Information
Storage Condition: |
-20°C |
Shipping Condition: |
Gel Pack |
Shelf Life: |
36 months |